Article
Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients.
Clinical and experimental immunology - 1 Jul 2011
Frakking F N J, Brouwer N, Dolman K M, van Woensel J B M, Caron H N, Kuijpers T W, van de Wetering M D
Abstract excerpt
Deficiency of mannose-binding lectin (MBL) has been suggested to influence duration of febrile neutropenia and prognosis in paediatric oncology patients. However, there is no consensus on the definition of MBL deficiency. In a cohort of children with cancer, we investigated (i) how to determine MBL deficiency and (ii) whether MBL is a prognostic factor for disease severity. In 222 paediatric oncology patients, 92...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
